Policy & Medicine

Acadia Healthcare Reaches $19.85 Million Settlement to Resolve False Claims Act…

Thomas Sullivan Nov 12, 2024 0

Acadia Healthcare Company, Inc., has reached a settlement agreement with the United States Department of Justice (DOJ) to resolve allegations that it violated the False Claims Act and certain state statutes by knowingly billing for medically unnecessary inpatient behavioral health services, or for services that did not meet federal and state…

Policy and Medicine Compliance Update – November 2023…

Thomas Sullivan Dec 1, 2023 0

Policy and Medicine Compliance Update October 2023 Issue…

Thomas Sullivan Oct 20, 2023 0

Acadia Healthcare Reaches $19.85 Million Settlement to Resolve…

CVS Subsidiary Reaches $60 Million Settlement Over False Claims…

Oak Street Health, a wholly-owned subsidiary of CVS Health since 2023, has agreed to pay $60 million to resolve allegations that it violated the False Claims Act (FCA) by paying kickbacks to third…

Announcing the Launch of the This Week in Policy and Medicine…

We are excited to announce the debut of the This Week in Policy and Medicine Podcast, a weekly series that brings you the latest insights and analyses from the intersection of healthcare policy and…

What a Trump Presidency Could Mean for the Life Sciences…

With Donald Trump now confirmed as the President-elect, the life sciences industry is bracing for significant policy shifts that could impact everything from drug pricing to regulatory practices.…

HHS OIG’s Mary Riordan Outlines New Compliance Priorities at…

Mary Riordan, Senior Counsel at the US Health and Human Services Office of Inspector General (HHS-OIG) provided significant updates on current HHS-OIG initiatives, enforcement actions, and upcoming…

Teva Pharmaceuticals Settles for $450 Million: The DOJ’s Latest…

The United States Department of Justice (DOJ) recently announced that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. will pay $450 million to resolve allegations of violating the…

Teva Pharmaceuticals Fined €462.6 Million Over Anti-Competitive…

On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its market dominance by delaying competition for Copaxone, a leading multiple…

HHS OIG Says Humana Received More than $13 Million in CMS…

The United States Department of Health and Human Services Office of Inspector General (HHS OIG) recently released results from its audit of Humana Health Plan, Inc. In the audit, HHS OIG was reviewing…

John Marshall Oncology Unscripted “Gut Feeling: Is Our…

In Episode 8 of Oncology Unscripted, Dr. John Marshall explores the intricate relationship between the human microbiome and cancer treatment outcomes. This episode, titled "Gut Feeling: Is Our…

FDA Releases Draft Guidance on Randomized Controlled Drug Trials…

Recently, the United States Food and Drug Administration (FDA) issued a draft guidance, Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice…

United States Agencies Release New Final Rules Implementing the…

The United States Departments of Health and Human Services (HHS), Labor, and the Treasury (collectively, the Departments) released new final rules implementing the Mental Health Parity and Addiction…

CMS Proposes Changes to Reporting and Returning Medicare Parts A…

Tucked into the Physician Fee Schedule is a provision that should be of interest to False Claims Act attorneys. Regarding Medicare overpayments, CMS proposed to change Medicare regulations regarding…